ClinicalTrials.Veeva

Menu

Incorporating Healthy Living Strategies to Aid in Recovery After Acute Pulmonary Embolism (ERASE-PE)

University of Rochester logo

University of Rochester

Status

Enrolling

Conditions

Acute Pulmonary Embolism

Treatments

Behavioral: Healthy Living Intervention-2
Behavioral: Healthy Living Intervention-1

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06784492
STUDY00009895
1K23HL171867 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of the ERAsE-PE study is to determine whether two different healthy living strategies (along with anticoagulation) might aid in recovery after a patient is hospitalized for pulmonary embolism. Specifically, Investigators will compare changes in Cardiac Effort (#heart beats used during the 6-minute walk test/walk distance) measured after an 8-week program.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. English speaking (>18 years old). Daily messages will be sent in English.

  2. Acute PE with at least one of the following:

    1. any right ventricular enlargement or dysfunction on echocardiogram;
    2. CT Angiogram reporting any right ventricular enlargement; or
    3. elevated cardiac biomarker (NT-pro BNP or troponin above baseline). Criteria for enrollment will be included on source document.
  3. Rate controlled atrial arrythmias (resting heart rate <110 beats/m) are eligible for enrollment. This includes atrial fibrillations. This is standard of care management for atrial fibrillation.

  4. Subjects do need to take prescribed anticoagulation.

Exclusion criteria

  1. Pregnancy.
  2. Cardiac Effort >3.5 beats/m during 6MWT.
  3. Resting tachycardia >110 beats/m at hospital discharge.
  4. Chronic Thromboembolic Pulmonary Hypertension
  5. Systolic blood pressure >180 mmHg at hospital discharge.
  6. Inability to walk.
  7. Estimated prognosis <12 months at the time of discharge due to underlying co-morbidities (e.g., cancer).
  8. Advanced neurologic disease and would not be able to comply with the messages.
  9. Lack of access to email or text messaging 10. Inability or unwillingness to follow daily instructions.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

100 participants in 2 patient groups

Healthy Living Intervention-1
Experimental group
Description:
Participants who receive daily messages about a healthy intervention.
Treatment:
Behavioral: Healthy Living Intervention-1
Healthy Living Intervention-2
Active Comparator group
Description:
Participants who receive daily messages about a different healthy intervention.
Treatment:
Behavioral: Healthy Living Intervention-2

Trial contacts and locations

1

Loading...

Central trial contact

Daniel J Lachant, DO

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems